Mini Cart

  • No products in the cart.

EpiScript-RNase H- Reverse Transcriptase, 25,000 units

$355.00

An optimised reverse transcriptase system for the production of full-length cDNA. Produce full-length cDNA with RNAse H- mutant Achieve higher specificity at elevated temperatures, up to 55°C EpiScript™ Rnase H- Reverse Transcriptase...

NAME SIZE ID AVAILABLITY VENDOR Your PRICE ORDER
EpiScript-RNase H- Reverse Transcriptase, 25,000 units EACH ERT12925K In stock or 2-3 weeks Lucigen $355.00
PRODUCT INFORMATION

An optimised reverse transcriptase system for the production of full-length cDNA.

  • Produce full-length cDNA with RNAse H- mutant
  • Achieve higher specificity at elevated temperatures, up to 55°C

EpiScript™ Rnase H- Reverse Transcriptase (EpiScript RT), an alternative to SuperScript® II Reverse Transcriptase, is a recombinant MMLV reverse transcriptase with greatly reduced RNase H activity. It is highly efficient at producing full-length cDNA from long RNA templates. EpiScript RT is capable of producing cDNA from as little as 50 pg of total RNA for real-time RT-PCR (qRT-PCR) analysis and other applications.

Applications

  • First-strand cDNA synthesis for subsequent PCR or real-time PCR.

Benefits

  • Recombinant MMLV reverse transcriptase with greatly reduced RNase H activity
  • Active at temperatures up to 55°C
  • Highly efficient at producing full-length cDNA from as little as 50 pg of total RNA
  • Best value in an RNase H- Reverse Transcriptase

Storage: Store only at -20°C in a freezer without a defrost cycle.

Storage Buffer: EpiScript RT is supplied in a 50% glycerol solution containing 50 mM Tris-HCl (pH 7.5), 100 mM sodium chloride, 1 mM DTT, 0.1 mM EDTA, and 0.1% Triton® X-100.

Unit Definition: One unit of EpiScript RT catalyzes the incorporation of 1 nmol of dTTP into acid-insoluble material in 10 minutes at 37°C using saturating amounts of oligo(dT)-primed poly(rA) as template.

Contaminating Activity Assays: EpiScript RT is free of detectable exonuclease, endonuclease, and RNase activities.

Figure 1

Figure 1. EpiScript™ Reverse Transcriptase performed equally or better than comparable reverse transcriptases from other vendors. First- strand synthesis reactions were assembled according to manufacturer´s specifications. Input RNA was 1 µg of Jurkat total RNA (Ambion®). Reactions were primed using 50 ng of poly-T(16-18) DNA. 2nd strand qPCR was performed using Bio-Rad iQ SYBR mastermix and gene-specific primers that yielded 250-350 bp amplicons. Reactions were repeated 4-fold. PGDF-R (Platelet Derived Growth Factor Receptor), TNF (Tumor Necrosis Factor), IL-1b (Interleukin-1 beta), IL-2 (Interleukin 2). Image courtesy of Matthew Kellinger, Illumina® Inc.

Figure 2A Figure 2B Figure 2 (click to enlarge). EpiScript™ Reverse Transcriptase produces similiar transcript coverage independent of transcript length. EpiScript was used to prime first strand cDNA either from total RNA using oligo-dT (left panel) or polyA+ selected RNA with random hexamers (right panel). The cDNA was converted into Illumina®-compatible libraries and sequenced. The reads were aligned to transcripts based upon various length classes and read density plotted relative to the percent distance from the 5´ end of the transcripts; 0% refers to the 5´ end and 100 % is the 3´ end. As expected, oligo-dT priming results in a more pronounced 3´ bias than random priming.

 

Figure 3 Figure 3. Use of EpiScript® Reverse Transcriptase for first strand cDNA results in detection of similar transcript categories independent of input amount. EpiScript RT was used to random prime 5 ng or 50 pg of human total RNA and the cDNA was converted into libraries for Illumina® sequencing. Reads were aligned using Tophat and annotated with Cufflinks and the percentage of each major category is visualised as a pie chart. Equivalent results are observed for both 5 ng and 50 pg of input RNA.